Welcome to the Division of Nephrology and the University of Arizona Kidney Disease Program. We are proud that U.S. News & World Report has ranked our program in the top 50 in the country (2016, 2015) and continues to rate us as high performing for patient care. As the only academic division of nephrology in the state of Arizona, our goal is to provide high quality clinical nephrology care to our patients, to develop innovative and topical research programs that will impact upon the care that we deliver to our patients, and to be a teaching and training resource to our community...

Prabir Roy-Chaudhury, MD, PhD, FRCP (Edin)
Chief, Division of Nephrology

Nephrology

The Division of Nephrology in the University of Arizona Department of Medicine and Banner University Medical Center – Tucson has active programs in clinical nephrology, teaching and training of fellows and residents, and a range of research opportunities. An important focus of the division is to emphasize translational and multi-disciplinary programs that truly go from bedside to bench to bedside in advancing patient care solutions.

At the clinical level, U.S. News & World Report has ranked nephrology care here among the top 50 programs in the country. Division faculty members care for patients with acute kidney injury, glomerulonephritis, complex hypertension, bladder and kidney stones, and chronic kidney disease (CKD). We are one of only four kidney transplant programs in the state of Arizona and have had a recent surge in kidney transplant activity, which has greatly benefitted our community. We also care for an increasing number of patients on hemodialysis, and have a growing home dialysis program (both hemodialysis and peritoneal dialysis) as well. An important and unique strength has been our partnership with Dialysis Clinics Inc. (DCI) to create a nocturnal hemodialysis program.

Faculty members from the Division of Nephrology are also involved in multiple clinical trials (more than 10 trials at present) targeting diverse kidney problems such as chronic kidney disease, kidney transplantation, vascular access dysfunction and glomerulonephritis.

The Division of Nephrology also has vibrant research programs in CKD progression, organ transplantation, renal genomics, dialysis vascular access, device development and tissue engineering.

Last but not least, an important focus of the division is on mentorship. We recognize that our greatest strength is our faculty and fellows. And, while we are committed to growing our clinical and research portfolios, the most important thing that we want to grow and nurture is people—our staff, faculty and fellows!

News & Announcements

Teaser image for the University of Arizona Cancer Center
UA Cancer Center Issues Request for Proposals for Clinical Research Oversight Council Funding

The Clinical Research Oversight Council has oversight of clinical research activities at the University of Arizona Cancer Center. Investigator-initiated trial (IIT) concepts that request UACC funding support must be presented to the CROC for determination of funding. The deadline for new proposals is Jan. 10, 2019, with review to begin Jan. 18…


Laptop and security issues
College of Medicine to Require Encryption for University-owned Laptops, Service Starts Dec. 11

To preserve the confidentiality and integrity of university data and follow the University of Arizona’s security standards, the UA College of Medicine – Tucson is requiring the encryption of all university-owned laptops. Service for this 30-minute process begins Dec. 11 with ITS Helpdesk available 9 a.m.-4 p.m., Tuesdays, Thursdays and Fridays. Bring in your laptop at your convenience during those times…


Teaser image for story on Banner - UMC Tucson's inclusion in expansion of early access program for diagnostic test for IPF
Banner – UMC Tucson Included in Expansion of Early Access Program for Idiopathic Pulmonary Fibrosis Genomic Classifier

Banner – University Medical Center Tucson is among 20 U.S. medical centers now offering a new test from Veracyte Inc. to improve diagnosis of idiopathic pulmonary fibrosis via RNA sequencing of a transbronchial lung biopsy to determine if a genomic pattern is present that indicates the respiratory disease…